TrialBritish journal of cancer2017

Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach.

Yukinori Kurokawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.